OH2 Injection in Combination With HX008 for Melanoma.
Clinical trial NCT04616443 · RECRUITING
Trial details
- NCT number
- NCT04616443
- Sponsor
- Binhui Biopharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2025-11-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.